About DORC
DORC is a company based in Zuidland (Netherlands) founded in 1983 was acquired by ZEISS in December 2023. DORC offers products and services including EVA NEXUS™, Trocars, Vitrectomy cutters, Endoillumination, and Laser probes. DORC operates in a competitive market with competitors including Bausch & Lomb, Dopavision, Appasamy Associates, Katalyst Surgical and Lamellar, among others.
- Headquarter Zuidland, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DORC
DORC offers a comprehensive portfolio of products and services, including EVA NEXUS™, Trocars, Vitrectomy cutters, Endoillumination, and Laser probes.
Advanced system for vitreoretinal and cataract surgery
Tools for minimally invasive ophthalmic procedures
Devices for removing vitreous humor in eye surgery
Lighting tools for enhanced visibility during surgery
Probes for precise laser-based eye treatments
Stain for cataract procedures to improve visibility
People of DORC
Unlock access to complete
Funding Insights of DORC
Investors in DORC
DORC has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include ZEISS, Eurazeo and Van Lanschot Kempen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment arm of Rabobank, focusing on equity capital provision.
|
Locked | Locked | Locked | |
|
Private equity and debt investments are managed across multiple sectors.
|
Locked | Locked | Locked | |
|
Montagu Private Equity is engaged in mid-market business investments.
|
Locked | Locked | Locked |
Investor details for DORC
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DORC
Investment portfolio details for DORC
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DORC
Detailed financials for DORC
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dorc Comparisons
Peer comparison for DORC
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DORC
DORC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bausch & Lomb, Dopavision, Appasamy Associates, Katalyst Surgical and Lamellar, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ophthalmic pharmaceuticals and instruments are developed for eye care.
|
|
| Locked | Locked | Locked |
Digital therapeutics for myopia are developed via retinal light stimulation.
|
|
| Locked | Locked | Locked |
Ophthalmic instruments and pharmaceutical products are developed for eye care.
|
|
| Locked | Locked | Locked |
Titanium ophthalmic surgical instruments are manufactured and repaired.
|
|
| Locked | Locked | Locked |
Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies
|
|
| Locked | Locked | Locked |
Precision instruments for eye surgery are designed and manufactured.
|
Detailed competitors of DORC
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dorc
Complete news archive for DORC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DORC
DORC was founded in 1983 and raised its 1st funding round 26 years after it was founded.
DORC is headquartered in Zuidland, Netherlands. It is registered at Zuidland, South Holland, Netherlands.
Thierry Leclercq is the current CEO of DORC.
DORC, established in 1983, excels in life sciences, ophthalmology, developing medical devices, therapy, and diversified. Ophthalmic research center. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
DORC's top competitors include Bausch & Lomb, Appasamy Associates and Katalyst Surgical.
DORC offers EVA NEXUS™, Trocars, Vitrectomy cutters, Endoillumination, and 2 more products and services.
DORC has 5 investors. Key investors include ZEISS, Eurazeo, Van Lanschot Kempen, Rabo Investments, and Montagu Private Equity.